Buradasınız

Anasayfa » Content

Erişkin Zona: Olgu Serisi ve Derleme

Adult Herpes Zoster: Case Series and Review

Journal Name:

  • Uludağ Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2008

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
This case series showed that the epidemiology, pathogenesis, natural history, common symptoms, treatment, and prevention of zoster disease. Anyone infected with varicella virus in childhood is at risk for reactivation of dormant virus and the onset of zoster disease, although it occurs with increasing frequency in the elderly as a result of waning of cell-mediated immunity. The appearance of herpes zoster is sufficiently distinctive that a clinical diagnosis is usually accurate. Acyclovir, valacyclovir, brivudine, and famciclovir are approved for the treatment of herpes zoster. These drugs are well tolerated and are similar in terms of both efficacy and safety. Antiviral treatments can decrease the severity of zoster rash and pain but cannot prevent disease onset or completely eliminate the most frequent symptoms. The zoster vaccine may help prevent the onset of herpes zoster in the target population of those age 60 years and older. Herpes zoster ophthalmicus is not in and of itself sight threatening or difficult to treat, but if the eye becomes involved, the risk to the patient increases, and the patient should be referred to an ophthalmologist. Herpes zoster is a disease associated with aging that can significantly impair quality of life for affected individuals. Here, we report teen cases of herpes zoster along with a review of the literature.
Bookmark/Search this post with
Abstract (Original Language): 
Bu olgu serisinde zonanın epidemiyolojisi, patogenezi, doğal seyri, sık semptomları, tedavisi ve korunma özetlendi. Varisella zoster virus çocukluk çağında su çiçeği tablosu ve latent virusun reaktivasyonu ile oluşan zonaya yol açar. Hücresel bağışıklığın azalması ile ve yaşlılıkta sıklığı artar. Zonanın görülmesi klinik doğru tanı için yeterlidir. Asiklovir, valasiklovir, brivudine, famsiklovir zona tedavisinde kullanılabilir. Bu ilaçların etki ve güvenliği benzerdir. Antiviral tedavilerle zona döküntüsü ve ağrısının şiddeti azalmıştır. Hastalığın başlamasında, sık semptomların yok edilmesinde yararı yoktur. Altmış yaş üstünde hedef grupta zoster aşısı hastalıktan korunmada yararlı olabilir. Göz tutulumunda tedavi zor olabilir, hastalar göz hekimine yönlendirilebilir. Zonada yaşam kalitesi etkilenir. Biz burada on zonalı hastayı literatür derlemesi ile sunduk.
FULL TEXT (PDF): 
PDF icon arastirmax-eriskin-zona-olgu-serisi-derleme.pdf
  • 3
123-125
  • Turkish

REFERENCES

References: 

1. Gnann JW Jr, Whitley RJ. Clinical practice: herpes zoster. N
Engl J Med 2002; 347:340-6.
2. Schmader K. Herpes zoster in older adults. Clin Infect Dis
2001; 32:1481-6.
3. Whitley RJ. Varicella-zoster virus infections. In: Kasper LD,
Braunwald E, Fauci SA, Hauser LS, Longo LD, Jameson LJ
(eds). Harrison’s Principles Internal Medicine.16th ed. United
States of America, McGraw-Hill, 2005; pp. 1042-45.
4. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of
herpes zoster. Arch Intern Med 1995; 155:1605-9.
5. Weinberg JM. Herpes zoster: epidemiology, natural history,
and common complications. J Am Acad Dermatol 2007;
57:S130-5.
6. Tyring SK. Management of herpes zoster and postherpetic
neuralgia. J Am Acad Dermatol 2007; 57:S136-42.
7. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 1996;
9:361-81.
8. Bennett GJ. Hypotheses on the pathogenesis of herpes zoster
associated pain. Ann Neurol 1994; 35(Suppl):S38-41.
9. Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM,
Underwood R, Holmberg SD. Herpes zoster and human
immunodeficiency virus infection. J Infect Dis 1992; 166:1153-
6.
10. Ragozzino MW, Melton LJ 3rd, Kurland LT, Chu CP, Perry
HO. Risk of cancer after herpes zoster: a population-based
study. N Engl J Med 1982; 307:393-7.
11. Yamamoto M, Mine H, Akazawa K, Maehara Y, Sugimachi K.
Gastrointestinal cancer and herpes zoster in adults.
Hepatogastroenterology 2003; 50:1043-6.
12. Matsumoto R, Yoshida T, Tabata K, Nakagawa S, Yanagisawa
N. [A patient with thyroid carcinoma who developed
consciousness disturbance during acyclovir administration for
herpes zoster] Rinsho Shinkeigaku 1996; 36:590-3.(abstract)
13. Feld R, Evans WK, DeBoer G. Herpes zoster in patients with
carcinoma of the lung. Am J Med 1982; 73:795-801.
14. Wood MJ, Shukla S, Fiddian AP, Crooks RJ. Treatment of
acute herpes zoster: effect of early (<48 h) versus late (48-72 h)
therapy with acyclovir and valaciclovir on prolonged pain. J
Infect Dis 1998; 178:Suppl 1:S81-S84.
15. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations
for the management of herpes zoster. Clin Infect Dis 2007; 44
Suppl 1:S1-26.
16. Ahmed AM, Brantley JS, Madkan V, Mendoza N, Tyring SK.
Managing herpes zoster in immunocompromised patients.
Herpes 2007; 14:32-6.
17. Çevik IÜ. Zona Hastalığı Ve Zona Sonrası Kalıcı Ağrı (PostHerpetik Nevralji) Ağrı 2004;16:17-24
18. Levin MJ, Barber D, Goldblatt E, et al. Use of a live attenuated
varicella vaccine to boost varicella-specific immune responses
in seropositive people 55 years of age and older: duration of
booster effect. J Infect Dis 1998; 178:Suppl 1:S109-S112.
19. Tapısız A, Çiftçi E. Suçiçeği Ve Suçiçeği Aşısı. Turkiye Klinikleri J Pediatr 2007; 3:81-88.

Thank you for copying data from http://www.arastirmax.com